Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 10.1.2024Haleon Czech Republic s.r.o. (HLE)8568COtrivin Plus 1 mg/ml + 50 mg/ml (aer nao 1x10 ml (fľ.HDPE))9.1.2024Z
 9.1.2024Pharmathen S.A. (PRS)12324Matever 100 mg/ml infúzny koncentrát (con inf 10x5 ml/500 mg (liek.inj.skl.))15.1.2024O
 8.1.2024Teva B.V. (TEV-NL-4)1627CEzetimib/simvastatín Teva B.V. 10 mg/40 mg (tbl 100x10 mg/40 mg (blis.OPA/Al/PVC/Al))5.1.2024O
 8.1.2024GlaxoSmithKline Biologicals S.A. (GAG)45411Boostrix Polio (sus iru 10x0,5 ml (striek.skl.napl.s ihlou))2.1.2024O
 8.1.2024Janssen - Cilag International N.V. (JNS)6807DJCOVDEN injekčná suspenzia (pôvodne COVID-19 Vaccine Janssen) (sus inj 10x2,5 ml (liek.inj.skl.))31.3.2024Z
 8.1.2024Berlin-Chemie AG (BCE)9771CProstamol uno (cps mol 90x320 mg (blis.PVC/PVDC/Al))8.1.2024O
 8.1.2024Novartis Europharm Limited (NEH-IE)0816ELeqvio 284 mg injekčný roztok v naplnenej injekčnej striekačke (sol inj 1x1,5 ml/284 mg (striek.inj.skl.+chránič ihly))8.1.2024U
 8.1.2024AGmed s.r.o. (AGQ)3952EParacetamol AGmed 500 mg (tbl 20x500 mg (blis.PVC/PVDC/Al))15.12.2023U
 8.1.2024G.V.Pharma, a.s. (GVP)51023V PNC 1000 (tbl flm 30x1000 mg (blister))8.1.2023O
 5.1.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)0506BRamomark 5 mg/5 mg tvrdé kapsuly (cps dur 28x5 mg/5 mg (blis.PA/Al/PVC/Al))1.4.2024Z
 5.1.2024AbbVie Deutschland GmbH & Co. KG (ABV-DE)2193CVenclyxto 100 mg filmom obalené tablety (tbl flm 14 (7x2)x100 mg (blis.PVC/PE/PCTFE/Al-jednotl.dávka))1.3.2024Z
 4.1.2024N.V. Organon (ORG-NL)58165ASMANEX 400 µg (plv inh 1x60 dávok (inh.plast.viacdávkový))4.1.2024O
 4.1.2024N.V. Organon (ORG-NL)44639Aerinaze 2,5 mg/120 mg tablety s riadeným uvoľňovaním (tbl mod 10x2,5 mg/120 mg (blis.PCTFE/PVC/Al))29.12.2023R
 4.1.2024B.Braun Melsungen AG (BME)0018AParacetamol B. Braun 10 mg/ml (sol inf 10x50 ml/500 mg (fľ.LDPE))22.1.2024R
 4.1.2024KRKA, d.d., Novo mesto (KRK-2)02594Co-Valsacor 320 mg/12,5 mg filmom obalené tablety (tbl flm 28x320 mg/12,5 mg (blis.PVC/PE/PVDC/Al))8.1.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)